1885P Pexa-vec (thymidine kinase-deactivated vaccinia virus plus GM-CSF) in combination with cemiplimab (REGN2810; ANTI-PD-1) for metastatic or unresectable renal cell carcinoma REN026: Results from a phase II study
| Autor: | Rha, S.Y., Bae, W.K., Kim, C., Oh, S.Y., Lee, H.W., Park, K., Mar, N., Kichenadasse, G., Ha, H.K., Pachynski, R., Park, I., Park, K.H., Kim, S.H., Folefac, E., Mathias, M.D., Seebach, F., Ma, S., Carranza, L., Beom, S-H., Merchan, J.R. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S1013-S1014 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|